CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
95.02%
Total 13F principal
$276,338,000
Principal change
+$12,894,000
Total reported market value
$262,789,000
Number of holders
21
Value change
+$8,487,241
Number of buys
10
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q3 2016

As of 30 Sep 2016, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $276,338,000 in principal (par value) of the bond. The largest 10 bondholders included Partner Fund Management, L.P., BAKER BROS. ADVISORS LP, QVT Financial LP, PointState Capital LP, Allianz Asset Management GmbH, CREDIT SUISSE AG/, AMERIPRISE FINANCIAL INC, CAPSTONE INVESTMENT ADVISORS, LLC, ADVENT CAPITAL MANAGEMENT /DE/, and CITADEL ADVISORS LLC. This page lists 21 institutional bondholders reporting positions for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.